Literature DB >> 1816111

Cerebrospinal fluid penetration of cefmenoxime in children with bacterial meningitis.

A Eicken1, J G Schöber, R Roos, K Machka.   

Abstract

Blood and cerebrospinal fluid (CSF) concentrations of cefmenoxime were determined either microbiologically or by means of HPLC in 20 children with proven or suspected bacterial meningitis. Sixteen children suffered from bacterial meningitis: causative organisms were Haemophilus influenzae type b (n = 10), Streptococcus pneumoniae (n = 4) and Neisseria meningitidis (n = 2). In these patients the cefmenoxime concentration in the CSF ranged from 0.9 to 12.2 mg/l, with a mean concentration of 4.63 mg/l 1.5-3 h after the last intravenous cefmenoxime application and 24-48 h after initiating therapy with 200 mg cefmenoxime/kg/d in four doses. In eight cases the bactericidal titers of the CSF were examined during therapy. Titers between 1:64 and 1:2,048, exceeding the minimal bactericidal concentration, were found. After five doses of cefmenoxime 50 mg/kg, two CSF cultures showed bacterial growth: one H. influenzae (bactericidal titer in CSF 1:256) and one S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1816111     DOI: 10.1007/BF01726450

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Current therapy of bacterial sepsis and meningitis in infants and children: a poll of directors of programs in pediatric infectious diseases.

Authors:  B M Word; J O Klein
Journal:  Pediatr Infect Dis J       Date:  1988-04       Impact factor: 2.129

2.  Reversible ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  U B Schaad; J Wedgwood-Krucko; H Tschaeppeler
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

3.  Penetration of cefmenoxime into cerebrospinal fluid of patients with bacterial meningitis.

Authors:  G Humbert; P Veyssier; J B Fourtillan; A Bryskier; F Borsa; P Y Lallement; G Bonmarchand
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

4.  The penetration of cefmenoxime into cerebrospinal fluid across non-inflamed meninges.

Authors:  K V Rolston; P H Chandrasekar; B R Smith; J L LeFrock
Journal:  J Antimicrob Chemother       Date:  1983-11       Impact factor: 5.790

5.  Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study.

Authors:  K Machka; I Braveny; H Dabernat; K Dornbusch; E Van Dyck; F H Kayser; B Van Klingeren; H Mittermayer; E Perea; M Powell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

6.  Ampicillin in Haemophilus influenzae meningitis. Clinicopharmacologic evaluation of intramuscular vs intravenous administration.

Authors:  H D Wilson; K C Haltalin
Journal:  Am J Dis Child       Date:  1975-02

7.  Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.

Authors:  P C Fuchs; R N Jones; C Thornsberry; A L Barry; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

8.  Absorption, distribution and excretion of cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.

Authors:  K Tsuchiya; Y Kita; I Yamazaki; M Kondo; Y Noji; T Fugono
Journal:  J Antibiot (Tokyo)       Date:  1980-12       Impact factor: 2.649

9.  The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers.

Authors:  S M Harding; A J Monro; J E Thornton; J Ayrton; M I Hogg
Journal:  J Antimicrob Chemother       Date:  1981-09       Impact factor: 5.790

10.  Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.

Authors:  M C Nahata; D E Durrell; W J Barson
Journal:  Chemotherapy       Date:  1986       Impact factor: 2.544

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.